Pycnogenol Protects Against Rotenone-Induced Neurotoxicity in PC12 Cells Through Regulating NF-κB-iNOS Signaling Pathway

被引:18
作者
Gao, Bo [1 ]
Chang, Chongwang [1 ]
Zhou, Jie [2 ]
Zhao, Tianzhi [1 ]
Wang, Chao [1 ]
Li, Chen [1 ]
Gao, Guodong [1 ]
机构
[1] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710038, Peoples R China
[2] Lanzhou Mil Reg Gen Hosp, Dept Neurosurg, Lanzhou, Peoples R China
关键词
NITRIC-OXIDE SYNTHASE; PARKINSONS-DISEASE; OXIDATIVE STRESS; INDUCED APOPTOSIS; MPTP MODEL; MITOCHONDRIAL DYSFUNCTION; DOPAMINE METABOLISM; ACTIVATION; EXPRESSION; INHIBITION;
D O I
10.1089/dna.2015.2953
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by dopaminergic neurons degeneration and oxidative damage may underlie this process. However, there are still no efficient drugs to cure the disease. Pycnogenol (PYC) isolated from the procyanidin-rich French maritime pine (Pinus maritime) bark has shown various antioxidant activities in previous studies. In this study, we explored its effect against rotenone (Rot)-induced neurotoxicity and the underlying mechanisms in PC12 cells. Using Rot-induced cell model of PD, we found that PYC treatment significantly increased cell viability and decreased cell apoptosis in Rot-treated PC12 cells in a dose-dependent manner. Furthermore, data showed that PYC markedly reduced inducible nitric oxide synthase (iNOS)-nitric oxide (NO) signaling in Rot-treated PC12 cells. Pretreatment with the iNOS-specific inhibitor significantly attenuated Rot-induced neurotoxicity. Moreover, PYC was found to be capable of reducing Rot-induced NF-B activation. Blocking NF-B signaling with its inhibitor mimicked the biological effect of PYC on Rot-induced iNOS and NO expression levels, as well as neurotoxicity in PC12 cells, suggesting that the NF-B-iNOS signaling pathway was likely to participate in the PYC-mediated protective progress. Our results suggest that PYC protects against Rot-induced neurotoxicity in PC12 cells, and the mechanism may be associated with the downregulation of NF-B-iNOS signaling pathway.
引用
收藏
页码:643 / 649
页数:7
相关论文
共 43 条
[31]  
RONG YQ, 1995, BIOTECHNOL THER, V5, P117
[32]   Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism [J].
Sai, Yan ;
Wu, Qiang ;
Le, Weidong ;
Ye, Feng ;
Li, Yunpeng ;
Dong, Zhaojun .
TOXICOLOGY IN VITRO, 2008, 22 (06) :1461-1468
[33]   Mitochondrial dysfunction and oxidative stress in Parkinson's disease [J].
Subramaniam, Sudhakar Raja ;
Chesselet, Marie-Francoise .
PROGRESS IN NEUROBIOLOGY, 2013, 106 :17-32
[34]   Neuroprotective Effects of Hesperidin, a Plant Flavanone, on Rotenone-Induced Oxidative Stress and Apoptosis in a Cellular Model for Parkinson's Disease [J].
Tamilselvam, Kuppusamy ;
Braidy, Nady ;
Manivasagam, Thamilarasan ;
Essa, Musthafa Mohamed ;
Prasad, Nagarajan Rajendra ;
Karthikeyan, Subburayan ;
Thenmozhi, Arokyasamy Justin ;
Selvaraju, Subash ;
Guillemin, Gilles J. .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2013, 2013
[35]   Rotenone, Paraquat, and Parkinson's Disease [J].
Tanner, Caroline M. ;
Kamel, Freya ;
Ross, G. Webster ;
Hoppin, Jane A. ;
Goldman, Samuel M. ;
Korell, Monica ;
Marras, Connie ;
Bhudhikanok, Grace S. ;
Kasten, Meike ;
Chade, Anabel R. ;
Comyns, Kathleen ;
Richards, Marie Barber ;
Meng, Cheryl ;
Priestley, Benjamin ;
Fernandez, Hubert H. ;
Cambi, Franca ;
Umbach, David M. ;
Blair, Aaron ;
Sandler, Dale P. ;
Langston, J. William .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2011, 119 (06) :866-872
[36]   Treatment of Parkinson Disease A 64-Year-Old Man With Motor Complications of Advanced Parkinson Disease [J].
Tarsy, Daniel .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (21) :2305-2314
[37]   Nuclear factor-κB activation is not involved in a MPTP model of Parkinson's disease [J].
Teismann, P ;
Schwaninger, M ;
Weih, F ;
Ferger, B .
NEUROREPORT, 2001, 12 (05) :1049-1053
[38]   Activation of microglia by human neuromelanin is NF-κB-dependent and involves p38 mitogen-activated protein kinase:: implications for Parkinson's disease [J].
Wilms, H ;
Rosenstiel, P ;
Sievers, J ;
Deuschl, G ;
Zecca, L ;
Lucius, R .
FASEB JOURNAL, 2003, 17 (01) :500-+
[39]   Mutation analysis and association studies of nuclear factor-κB1 in sporadic Parkinson's disease patients [J].
Wintermeyer, P ;
Riess, O ;
Schöls, L ;
Przuntek, H ;
Miterski, B ;
Epplen, JT ;
Krüger, R .
JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (09) :1181-1188
[40]  
XIE QW, 1994, J BIOL CHEM, V269, P4705